PSP Research »

Cytokinetics shares owned by PSP Research

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by PSP Research from 13F filings

Historical chart of PSP Research investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by PSP Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by PSP Research

Quarter filed Position value Share count Share price at filing
2025-12-31 $528k 8.3k 63.54

More positions owned by PSP Research

Ishares Tr 0-3 Mnth Treasry (SGOV)
Praxis Precision Medicines I Com New (PRAX)
Travere Therapeutics (TVTX)
Tyra Biosciences (TYRA)
Pharvaris N V (PHVS)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Celldex Therapeutics Com New (CLDX)
Cg Oncology (CGON)
Belite Bio Sponsored Ads (BLTE)
Ascendis Pharma A/s Sponsored Adr (ASND)
Apellis Pharmaceuticals (APLS)
Terns Pharmaceuticals (TERN)
Revolution Medicines (RVMD)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Bridgebio Pharma (BBIO)

View all positions for PSP Research

Top funds holding Cytokinetics

T. Rowe Price Investment Management
BlackRock
FMR
Vanguard Group
Wellington Management Company
State Street Corporation
Deep Track Capital
Geode Capital Management
Susquehanna International
Rtw Investments
Goldman Sachs Group
Polar Capital Holdings
Integral Health Asset Management
Woodline Partners
Citadel Advisors

View all funds holding Cytokinetics